About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Neurorehabilitation Devices Market Size, Top Share, Demand, Forecast to 2033
Neurorehabilitation Devices Market

Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Applications (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), By End-User (Rehabilitation Centers, Hospitals and Clinics, Home Care, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55613DR
Last Updated : October 22, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Neurorehabilitation Devices Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurorobotics
          1. By Value
        3. Brain-Computer Interface
          1. By Value
        4. Wearable Devices
          1. By Value
        5. Non-Invasive Stimulators
          1. By Value
        6. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Stroke
          1. By Value
        3. Parkinson’s Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Cerebral Palsy
          1. By Value
        6. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rehabilitation Centers
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Home Care
          1. By Value
        5. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurorobotics
          1. By Value
        3. Brain-Computer Interface
          1. By Value
        4. Wearable Devices
          1. By Value
        5. Non-Invasive Stimulators
          1. By Value
        6. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Stroke
          1. By Value
        3. Parkinson’s Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Cerebral Palsy
          1. By Value
        6. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rehabilitation Centers
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Home Care
          1. By Value
        5. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurorobotics
          1. By Value
        3. Brain-Computer Interface
          1. By Value
        4. Wearable Devices
          1. By Value
        5. Non-Invasive Stimulators
          1. By Value
        6. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Stroke
          1. By Value
        3. Parkinson’s Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Cerebral Palsy
          1. By Value
        6. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rehabilitation Centers
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Home Care
          1. By Value
        5. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurorobotics
          1. By Value
        3. Brain-Computer Interface
          1. By Value
        4. Wearable Devices
          1. By Value
        5. Non-Invasive Stimulators
          1. By Value
        6. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Stroke
          1. By Value
        3. Parkinson’s Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Cerebral Palsy
          1. By Value
        6. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rehabilitation Centers
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Home Care
          1. By Value
        5. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurorobotics
        1. By Value
      3. Brain-Computer Interface
        1. By Value
      4. Wearable Devices
        1. By Value
      5. Non-Invasive Stimulators
        1. By Value
      6. Others
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Stroke
        1. By Value
      3. Parkinson’s Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Cerebral Palsy
        1. By Value
      6. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Rehabilitation Centers
        1. By Value
      3. Hospitals and Clinics
        1. By Value
      4. Home Care
        1. By Value
      5. Others
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurorobotics
          1. By Value
        3. Brain-Computer Interface
          1. By Value
        4. Wearable Devices
          1. By Value
        5. Non-Invasive Stimulators
          1. By Value
        6. Others
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Stroke
          1. By Value
        3. Parkinson’s Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Cerebral Palsy
          1. By Value
        6. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Rehabilitation Centers
          1. By Value
        3. Hospitals and Clinics
          1. By Value
        4. Home Care
          1. By Value
        5. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Neurorehabilitation Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bioventus
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Ectron
    3. Hocoma
    4. Tyromotion Inc.
    5. Biometrics Ltd.
    6. DIH
    7. Medtronic
    8. Bionik Laboratories Corp. (BNKL)
    9. BioXtreme Ltd.
    10. Kinestica
    11. Kinova Inc.
    12. Ekso Bionics
    13. Neuro Rehab VR
    14. Saebo, Inc.
    15. Abbott
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global neurostimulation devices market size was valued at USD 6 billion in 2021 and is valued at USD 14 billion by 2030. The market is expected to grow at a CAGR of 13% during the forecast period (2022–2030). Factors such as increasing geri
Buy Now
Global Report
Rehabilitation Equipment Market Size The global rehabilitation equipment market size was valued at USD 22.04 billion in 2024 and is projected to grow from USD 23.98 billion in 2025 to reach USD 39.63 billion by 2033, exhibit
Buy Now
Global Report
Market Overview The global sinus dilation devices market size was valued at USD 2,573 million in 2022. It is estimated to reach USD 5,217 million by 2031, growing at a CAGR of 10.79% during the forecast period (2023–2031). Sinusitis is an inf
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.